Join the BNA Dementia Masterclass for an in-depth exploration of the latest advancements in dementia research.
The in-person masterclass took place on 4th June 2025 in London, and brought together world-leading experts for a full day of learning; share cutting-edge insights and diverse perspectives.
We are now delighted to present online access the Dementia Masterclass. Enjoy over four hours of expert-led content, available to watch at your convenience - anytime, anywhere.
“[The Masterclass] is perfect for curious clinicians, interdisciplinary scientists looking for some top-level training, or early-career neuroscientists/neurologists wishing to understand the field better.” - In person attendee
Course content outline:
Key learning outcomes:
Describe the key clinical features of dementia, including prevalence, symptomatology, diagnostic criteria, progression, and prognosis.
Identify the major diseases that cause dementia, such as Alzheimer’s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia.
Evaluate risk factors; including genetic, environmental, and lifestyle influences associated with the development of dementia.
Understand and interpret the role of biomarkers in the early detection, diagnosis, and monitoring of dementias, and how they link neuroscience to clinical practice.
Explain the neuropathological mechanisms and neurodegenerative processes involved in various dementias, as well as current research advances and remaining knowledge gaps in the field.
Critically assess current and emerging therapeutic approaches to dementia treatment, including pharmacological and non-pharmacological interventions, and understand the structure of clinical trials and regulatory frameworks guiding dementia research and care.
Online delegates will be able to apply for a certificate of attendance.
Once registration is complete, delegates will be sent a secure link via email to the online course content which is hosted, and can be viewed on the BNA website.
Imperial College London
University of Gothenburg, University College London, UKDRI
University of Cambridge
Professor Carol Brayne CBE is a Professor of Public Health Medicine and Co-Director of Cambridge Public Health Interdisciplinary Centre at the University of Cambridge. She is a medically qualified epidemiologist and public health academic. Her main research has been longitudinal studies of older people following changes over time with a public health perspective and focus on the brain. She is the lead principal investigator in the MRC CFA Studies and other population-based studies and has played a lead role in teaching and training in epidemiology and public health at Cambridge University. She is a Fellow of the Academy of Medical Sciences and an NIHR Senior Investigator Emeritus.University College London
Jonathan Schott is a Professor of Neurology at the Dementia Research Centre, UCL Institute of Neurology, and an Honorary Consultant Neurologist at UCLH. His clinical practice and research are centred on the dementias with a focus on early accurate diagnosis, and detection of pre-symptomatic Alzheimer’s disease. He leads, amongst others a major longitudinal study exploring cognitive ageing and brain health in the MRC British 1946 birth cohort, and a study examining the utility of blood based biomarkers for Alzheimer’s disease in NHS memory clinics. He is a Fellow of the American Academy of Neurology, Fellow of the European Academy of Neurology, Senior Fellow of the Higher Education academy, MRC Investigator and an NIHR Senior Investigator. He has published more that 390 papers and co-edited the Oxford Textbook of Cognitive Neurology and Dementia. He is the recipient of the de Leon prize in neuroimaging and Bill Thies award for distinguished service from the US Alzheimer’s Association. He has a number of national and international leadership positions including chair emeritus of the International Society to Advance Alzheimer’s Research and Therapy, chair of the Association of British Neurology Clinical Advisory Group, member of the European Academy of Neurology Dementia Panel, and Chief Medical Officer for Alzheimer’s Research UK.University of Edinburgh
Prof Tara Spires-Jones, DPhil(Oxon), FMedSci runs a research group studying brain changes in ageing and neurodegenerative diseases including Alzheimer’s disease. Her laboratory studies the synaptic connections between neurons, which in a healthy brain allow learning and memory. The goal of the group is to understand the mechanisms of synapse degeneration and resilience in order to develop treatments that will promote recovery of brain function. Dr Spires-Jones received her DPhil from the University of Oxford and was an Assistant Professor at Massachusetts General Hospital and Harvard Medical School before returning to the UK to join the University of Edinburgh in 2013.
In addition to her research, Prof Spires-Jones is passionate about communicating scientific findings to the public and policy makers; increasing the rigour and reproducibility in translational neuroscience; promoting inclusivity and diversity in science; and supporting the career development of neuroscientists. She is a founding member of the FENS-Kavli Network of Excellence, which works to promote the future of European Neuroscience. She served as a member of the Scottish Science Advisory Council from 2016-2019 advising the Scottish Government on science policy, and in 2024 was elected a Fellow of the UK Academy of Medical Sciences. Tara served as President of the British Neuroscience Association from 2023-2025.
University of Gothenburg, University College London, UKDRI
Professor Henrik Zetterberg, MD, PhD, is a world-renowned expert in neurochemistry and fluid biomarkers for brain diseases, particularly neurodegenerative disorders like Alzheimer’s disease. He is a Professor at the University of Gothenburg, Sweden, and University College London (UCL), UK, and a senior consultant in clinical chemistry at Sahlgrenska University Hospital. He leads the UK DRI Fluid Biomarker Laboratory at UCL and is also a key member of the Hong Kong Center for Neurodegenerative Diseases.
With a background in molecular biology and medicine, Professor Zetterberg has published over 2,000 scientific articles and received numerous awards for his groundbreaking research. His work focuses on the development of biomarkers to diagnose and understand neurodegenerative diseases.
Please accept {{cookieConsents}} cookies to view this content